J R MacKinnon1, R M Knott, J V Forrester. 1. Department of Ophthalmology, Raigmore Hospital, Inverness IV2 3UJ, Scotland, UK. janermackinnon@hotmail.com
Abstract
AIM: To investigate L-selectin expression and shedding in patients with and without retinopathy and to determine if any observed changes are reflected by a functional change in the adhesion of leucocytes to an endothelial monolayer. METHODS: Age matched diabetic patients (26 with retinopathy, 19 without retinopathy) were compared to 24 non-diabetic controls to determine L-selectin surface protein expression, L-selectin mRNA production, and serum L-selectin levels by flow cytometry, RT-PCR, and ELISA, respectively. An adhesion assay was used to determine the binding of lymphocytes from the respective test groups to a monolayer of human endothelial cells. RESULTS: Significantly reduced (p = 0.004) L-selectin expression was demonstrated on lymphocytes (CD3+) from patients with diabetes compared to controls, the lowest levels being found in those with diabetic retinopathy (p = 0.004). L-selectin mRNA levels (p = 0.007) were significantly higher in the retinopathy group than in the no retinopathy group. Serum L-selectin levels were significantly higher (p = 0.04) in those with retinopathy compared to controls. Lymphocyte adhesion relative to control (100%) was essentially unchanged (84.0% (SD 27.7%), p = 0.15) for diabetic patients with no retinopathy and was markedly increased (192% (37.6%)) for those with retinopathy (p = 0.0001). CONCLUSION: Lymphocyte activation, reduced surface L-selectin, increased circulating L-selectin, and a corresponding increase in adhesion of patients' cells using an in vitro assay, is evident in people with diabetic retinopathy. This suggests a role for lymphocyte activation in the pathogenesis of diabetic retinopathy.
AIM: To investigate L-selectin expression and shedding in patients with and without retinopathy and to determine if any observed changes are reflected by a functional change in the adhesion of leucocytes to an endothelial monolayer. METHODS: Age matched diabeticpatients (26 with retinopathy, 19 without retinopathy) were compared to 24 non-diabetic controls to determine L-selectin surface protein expression, L-selectin mRNA production, and serum L-selectin levels by flow cytometry, RT-PCR, and ELISA, respectively. An adhesion assay was used to determine the binding of lymphocytes from the respective test groups to a monolayer of human endothelial cells. RESULTS: Significantly reduced (p = 0.004) L-selectin expression was demonstrated on lymphocytes (CD3+) from patients with diabetes compared to controls, the lowest levels being found in those with diabetic retinopathy (p = 0.004). L-selectin mRNA levels (p = 0.007) were significantly higher in the retinopathy group than in the no retinopathy group. Serum L-selectin levels were significantly higher (p = 0.04) in those with retinopathy compared to controls. Lymphocyte adhesion relative to control (100%) was essentially unchanged (84.0% (SD 27.7%), p = 0.15) for diabeticpatients with no retinopathy and was markedly increased (192% (37.6%)) for those with retinopathy (p = 0.0001). CONCLUSION: Lymphocyte activation, reduced surface L-selectin, increased circulating L-selectin, and a corresponding increase in adhesion of patients' cells using an in vitro assay, is evident in people with diabetic retinopathy. This suggests a role for lymphocyte activation in the pathogenesis of diabetic retinopathy.
Authors: D J Kilmartin; Z J Fletcher; J A Almeida; J Liversidge; J V Forrester; A D Dick Journal: Invest Ophthalmol Vis Sci Date: 2001-05 Impact factor: 4.799
Authors: F C Barouch; K Miyamoto; J R Allport; K Fujita; S E Bursell; L P Aiello; F W Luscinskas; A P Adamis Journal: Invest Ophthalmol Vis Sci Date: 2000-04 Impact factor: 4.799
Authors: K Miyamoto; S Khosrof; S E Bursell; R Rohan; T Murata; A C Clermont; L P Aiello; Y Ogura; A P Adamis Journal: Proc Natl Acad Sci U S A Date: 1999-09-14 Impact factor: 11.205
Authors: Satyajit Mohite; Fang Yang; Pooja A Amin; Giovana Zunta-Soares; Gabriela D Colpo; Laura Stertz; Ajaykumar N Sharma; Gabriel R Fries; Consuelo Walss-Bass; Jair C Soares; Olaoluwa O Okusaga Journal: PLoS One Date: 2017-03-23 Impact factor: 3.240
Authors: Samuela Pollack; Robert P Igo; Richard A Jensen; Mark Christiansen; Xiaohui Li; Ching-Yu Cheng; Maggie C Y Ng; Albert V Smith; Elizabeth J Rossin; Ayellet V Segrè; Samaneh Davoudi; Gavin S Tan; Yii-Der Ida Chen; Jane Z Kuo; Latchezar M Dimitrov; Lynn K Stanwyck; Weihua Meng; S Mohsen Hosseini; Minako Imamura; Darryl Nousome; Jihye Kim; Yang Hai; Yucheng Jia; Jeeyun Ahn; Aaron Leong; Kaanan Shah; Kyu Hyung Park; Xiuqing Guo; Eli Ipp; Kent D Taylor; Sharon G Adler; John R Sedor; Barry I Freedman; I-Te Lee; Wayne H-H Sheu; Michiaki Kubo; Atsushi Takahashi; Samy Hadjadj; Michel Marre; David-Alexandre Tregouet; Roberta Mckean-Cowdin; Rohit Varma; Mark I McCarthy; Leif Groop; Emma Ahlqvist; Valeriya Lyssenko; Elisabet Agardh; Andrew Morris; Alex S F Doney; Helen M Colhoun; Iiro Toppila; Niina Sandholm; Per-Henrik Groop; Shiro Maeda; Craig L Hanis; Alan Penman; Ching J Chen; Heather Hancock; Paul Mitchell; Jamie E Craig; Emily Y Chew; Andrew D Paterson; Michael A Grassi; Colin Palmer; Donald W Bowden; Brian L Yaspan; David Siscovick; Mary Frances Cotch; Jie Jin Wang; Kathryn P Burdon; Tien Y Wong; Barbara E K Klein; Ronald Klein; Jerome I Rotter; Sudha K Iyengar; Alkes L Price; Lucia Sobrin Journal: Diabetes Date: 2018-11-28 Impact factor: 9.337